| product Name |
Tylosin, [R-(R*,R*)]-2,3-dihydroxybutanedioate (salt) |
| Synonyms |
Tylosin tartrate salt; TYLOSINE TARTRATE; pharmasin; Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (salt); Tylosintartrate,BP; Tylosin tartrate; Tylosintartrate; [(2R,4E,6E,9R,11R,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside 2,3-dihydroxybutanedioate (salt); [(2R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside 2,3-dihydroxybutanedioate (salt); tylosin solution; tylosin hydrogen tartrate |
| Molecular Formula |
C50H83NO23 |
| Molecular Weight |
1066.1869 |
| InChI |
InChI=1/C46H77NO17.C4H6O6/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35;5-1(3(7)8)2(6)4(9)10/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3;1-2,5-6H,(H,7,8)(H,9,10)/b15-14+,23-18+;/t24-,25+,26-,27-,28+,29+,30?,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-;/m1./s1 |
| CAS Registry Number |
1405-54-5;74610-55-2 |
| EINECS |
215-781-5 |
| Molecular Structure |
![1405-54-5;74610-55-2 Tylosin, [R-(R*,R*)]-2,3-dihydroxybutanedioate (salt)](https://images-a.chemnet.com/suppliers/chembase/229/229881_1.gif)
|
| Boiling point |
1116.3°C at 760 mmHg |
| Flash point |
628.9°C |
| Water solubility |
H2O: 50 mg/mL, clear, yellow-green |
| Vapour Pressur |
0mmHg at 25°C |
| Hazard Symbols |
 Xn:有害物质;
|
| Risk Codes |
R42/43:吸入和皮肤接触会导致过敏;
|
| Safety Description |
S22:不要吸入粉尘‖S36/37;
|
|
